{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-004565","form_type":"8-K","ticker":"MBIO","cik":"0001680048","company_name":"MUSTANG BIO, INC.","filed_at":"2025-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.415723+00:00","generated_at":"2026-05-27T23:17:12.640064+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Mustang Bio effects 1-for-50 reverse stock split to regain Nasdaq compliance","bullets":["Outstanding shares reduced from ~64.8M to ~1.3M; split effective Jan 15, 2025.","Trading on split-adjusted basis under symbol MBIO begins Jan 16, 2025.","Reverse split intended to meet Nasdaq's $1.00 minimum bid price requirement.","No fractional shares issued; cash payment in lieu for fractional entitlements.","New CUSIP 62818Q302; board set final ratio on Jan 6, 2025 per prior stockholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-004565","json":"https://secwatch.observer/filing/0001104659-25-004565.json","markdown":"https://secwatch.observer/filing/0001104659-25-004565.md","text":"https://secwatch.observer/filing/0001104659-25-004565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680048/000110465925004565/0001104659-25-004565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680048/000110465925004565/tm253736d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:17:12.640064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}